Financials Filament Health Corp.
Equities
FLHLF
CA31685W1068
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0396 USD | -1.00% | +32.00% | -26.80% |
May. 14 | Filament Health Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 04 | Filament Health Corp. Announces Change to Board of Directors | CI |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 37.44 | 10.99 | 11.43 | 8.364 | - | - |
Enterprise Value (EV) 1 | 37.44 | 10.99 | 11.43 | 8.364 | 8.364 | 8.364 |
P/E ratio | -4.73 x | -0.85 x | - | - | - | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | 40.8 x | 7.28 x | 4.27 x | 3.21 x | 0.51 x |
EV / Revenue | - | 40.8 x | 7.28 x | 4.27 x | 3.21 x | 0.51 x |
EV / EBITDA | - | - | -3.29 x | -1.97 x | -0.89 x | 1.57 x |
EV / FCF | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 164,757 | 174,949 | 211,210 | 211,210 | - | - |
Reference price 2 | 0.2272 | 0.0628 | 0.0541 | 0.0396 | 0.0396 | 0.0396 |
Announcement Date | 3/31/22 | 3/31/23 | 4/2/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | - | 0.2694 | 1.569 | 1.959 | 2.603 | 16.33 |
EBITDA 1 | - | - | -3.469 | -4.252 | -9.38 | 5.34 |
EBIT 1 | -5.822 | - | -3.623 | -4.505 | -9.649 | 4.76 |
Operating Margin | - | - | -230.86% | -229.91% | -370.71% | 29.15% |
Earnings before Tax (EBT) | -7.442 | - | - | - | - | - |
Net income | -7.412 | - | - | - | - | - |
Net margin | - | - | - | - | - | - |
EPS | -0.0481 | -0.0739 | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/31/22 | 3/31/23 | 4/2/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | 0.126 | 0.0239 | 0.1256 | - | 0.246 | 1.275 | 0.2183 | 0.144 | 0.108 | 0.0252 |
EBITDA 1 | - | - | - | - | - | - | -0.8448 | -0.7849 | -0.5481 | -1.38 | -1.166 | -1.429 |
EBIT 1 | -1.825 | - | - | - | - | - | -0.8757 | -0.8241 | -0.5871 | -1.443 | -1.23 | -1.493 |
Operating Margin | - | - | - | - | - | - | -356.03% | -64.64% | -268.99% | -1,002.42% | -1,138.58% | -5,923.13% |
Earnings before Tax (EBT) | -1.929 | - | - | - | - | - | - | - | - | - | - | - |
Net income | -1.899 | - | - | - | - | -1.131 | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - |
EPS | -0.008010 | -0.007750 | -0.007750 | -0.007480 | -0.0517 | -0.007430 | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/31/22 | 5/16/22 | 8/15/22 | 11/10/22 | 3/31/23 | 8/14/23 | 11/14/23 | 4/2/24 | 5/14/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex | 0.1 | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 3/31/22 | 3/31/23 | 4/2/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-26.80% | 8.36M | |
+6.19% | 217B | |
+11.68% | 190B | |
+18.39% | 143B | |
+29.99% | 111B | |
+0.65% | 64.59B | |
+14.36% | 52.36B | |
+2.06% | 48.45B | |
-5.20% | 38.03B | |
-1.20% | 35.6B |
- Stock Market
- Equities
- FLHLF Stock
- Financials Filament Health Corp.